---
schema_version: "secwatch.filing_event.v1"
accession: "0000896264-25-000210"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2025-10-09T23:59:59+00:00"
generated_at: "2026-05-17T04:17:04.751552+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# USANA preliminary Q3 net loss $6.5M, sales $214M, tax rate spikes to 471%; full-year EPS guidance cut

## Summary
- Q3 net sales $214M (up from $200M YoY) but operating earnings fall to $1.2M from $15.6M.
- Diluted EPS loss $0.36 ($0.56 profit in Q3 2024); adjusted EPS loss $0.15.
- Effective tax rate 471% due to annual rate change from 45% to 65%, adding ~$7.5M in extra tax.
- Full-year sales expected at or near lower end of prior range; EPS below previously issued range.
- Hiya (DTC) sales softer but still expected to achieve double-digit growth for 2025.

## SEC filing metadata
- accession: 0000896264-25-000210
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2025-10-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000089626425000210/0000896264-25-000210-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000089626425000210/usna-20251009.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000896264-25-000210
- JSON: https://secwatch.observer/filing/0000896264-25-000210.json
- Plain text: https://secwatch.observer/filing/0000896264-25-000210.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.